Last $0.20 USD
Change Today +0.02 / 11.11%
Volume 13.3K
GTHP On Other Exchanges
Symbol
Exchange
OTC BB
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

guided therapeutics inc (GTHP) Snapshot

Open
$0.19
Previous Close
$0.18
Day High
$0.20
Day Low
$0.18
52 Week High
05/14/14 - $0.60
52 Week Low
01/15/15 - $0.15
Market Cap
16.0M
Average Volume 10 Days
164.5K
EPS TTM
$-0.15
Shares Outstanding
79.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GUIDED THERAPEUTICS INC (GTHP)

Related News

No related news articles were found.

guided therapeutics inc (GTHP) Related Businessweek News

No Related Businessweek News Found

guided therapeutics inc (GTHP) Details

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. The company primarily develops LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix. It is also developing a non-invasive test for the early detection of esophageal cancer using the technology platform. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is based in Norcross, Georgia.

30 Employees
Last Reported Date: 11/26/14
Founded in 1992

guided therapeutics inc (GTHP) Top Compensated Officers

Senior Vice President of Engineering and Secr...
Total Annual Compensation: $197.0K
Chief Scientific Officer
Total Annual Compensation: $243.0K
Compensation as of Fiscal Year 2013.

guided therapeutics inc (GTHP) Key Developments

Guided Therapeutics Provides an Update on FDA Review Time for LuViva® Advanced Cervical Scan

Guided Therapeutics Inc. announced that the U.S. Food and Drug Administration has not yet completed its review of the pre-market approval (PMA) application for the LuViva® Advanced Cervical Scan. The company has been in communication with the agency and is hoping to receive the agency's decision within the next several weeks.

Guided Therapeutics, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Guided Therapeutics Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenue contract and grant revenue of $22,000 compared to $86,000 for the same period a year ago. Operating loss was $2,415,000 compared to $1,640,000 last year. Net loss was $2,972,000 compared to $1,438,000 last year. Net loss attributable to common stockholders was $3,011,000 or $0.04 per basic and diluted share compared to $1,438,000 or $0.02 per basic and diluted share last year. Sales devices and disposables was $262,000 compared to $58,000 last year. For the nine months, the company reported revenue contract and grant revenue of $52,000 compared to $474,000 for the same period a year ago. Operating loss was $6,520,000 compared to $5,256,000 last year. Net loss was $6,685,000 compared to $5,002,000 last year. Net loss attributable to common stockholders was $6,813,000 or $0.09 per basic and diluted share compared to $6,173,000 or $0.09 per basic and diluted share last year. Sales devices and disposables was $586,000 compared to $306,000 last year.

Guided Therapeutics, Inc to Report Q3, 2014 Results on Nov 13, 2014

Guided Therapeutics, Inc announced that they will report Q3, 2014 results at 5:00 PM, Eastern Standard Time on Nov 13, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTHP:US $0.20 USD +0.02

GTHP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hologic Inc $32.57 USD -0.115
View Industry Companies
 

Industry Analysis

GTHP

Industry Average

Valuation GTHP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.5x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 12.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUIDED THERAPEUTICS INC, please visit www.guidedinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.